CannMed 2019

CannMed features the greatest minds in medical cannabis. With a booming industry anticipated to exceed $500B by 2028, understanding the complex science and its medical benefits for patients in need is how this conference series was born. Since our inaugural event at Harvard Medical School in 2016, we have been passionately driven to further the scientific and cultural dialogue. Medicinal Genomics invites all attendees or sponsors to experience firsthand why CannMed continues to lead the way in cannabis science.

This year, our speakers will address cannabis science, medicine, cultivation, and safety testing  to allow CannMed to fully explore the wide gamut of cannabis science, from seed to sale.